Patent · US Active

Hepatitis C inhibitor peptide analogs

US7696242B2 · kind B2 · utility

2Cited by
28References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 19, 2005
Grant dateApr 13, 2010
Priority date—
Expiry dateJan 10, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I):wherein R1, R2, R3, R4, R5, Y, n and m are as defined herein. The compounds are useful as inhibitors of HCV NS3 protease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.